Selecting precise reference normal tissue samples for cancer research using a deep learning approach
Billy ZengiD, Benjamin Scott GlicksbergiD, Yangyan LiiD, Bin CheniD
Abstract
BackgroundNormal tissue samples are often employed as a control for understanding disease mechanisms, however, collecting matched normal tissues from patients is difficult in many instances. In cancer research, for example, the open cancer resources such as TCGA and TARGET do not provide matched tissue samples for every cancer or cancer subtype. The recent GTEx project has profiled samples from healthy individuals, providing an excellent resource for this field, yet the feasibility of using GTEx samples as the reference remains unanswered.\n\nMethodsWe analyze RNA-Seq data processed from the same computational pipeline and systematically evaluate GTEx as a potential reference resource. We use those cancers that have adjacent normal tissues in TCGA as a benchmark for the evaluation. To correlate tumor samples and normal samples, we explore top varying genes, reduced features from principal component analysis, and encoded features from an autoencoder neural network. We first evaluate whether these methods can identify the correct tissue of origin from GTEx for a given cancer and then seek to answer whether disease expression signatures are consistent between those derived from TCGA and from GTEx.\n\nResultsAmong 32 TCGA cancers, 18 cancers have less than 10 matched adjacent normal tissue samples. Among three methods, autoencoder performed the best in predicting tissue of origin, with 12 of 14 cancers correctly predicted. The reason for misclassification of two cancers is that none of normal samples from GTEx correlate well with any tumor samples in these cancers. This suggests that GTEx has matched tissues for the majority cancers, but not all. While using autoencoder to select proper normal samples for disease signature creation, we found that disease signatures derived from normal samples selected via an autoencoder from GTEx are consistent with those derived from adjacent samples from TCGA in many cases. Interestingly, choosing top 50 mostly correlated samples regardless of tissue type performed reasonably well or even better in some cancers.\n\nConclusionsOur findings demonstrate that samples from GTEx can serve as reference normal samples for cancers, especially those do not have available adjacent tissue samples. A deep-learning based approach holds promise to select proper normal samples.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 48
- FWCI
- 3.06
- Field percentile
- top 7%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Cancer as a tissue anomaly: classifying tumor transcriptomes based only on healthy data
Thomas P. Quinn, Thin Nguyen, … Svetha Venkatesh·Frontiers in GeneticsPeer-reviewed·Jul 2, 2019
- When perfect is a warning: explanations expose shortcuts that accuracy hides in cancer gene-expression classifiers
Hamail Ayaz, Pooja Verma, … Ayodeji Olusegun Ibitoye·bioRxiv·Nov 3, 2026
- Analyzing cancer gene expression data through the lens of normal tissue-specificity
H. R. Frost·bioRxiv·Jan 25, 2021
- Identification of 12 cancer types through genome deep learning
Yingshuai Sun, Sitao Zhu, … Wenbin Chen·Scientific ReportsPeer-reviewed·Nov 21, 2019
- N-of-one differential gene expression without control samples using a deep generative model
Iñigo Prada-Luengo, Viktoria Schuster, … Anders Krogh·Genome biologyPeer-reviewed·Nov 16, 2023
- Attentive deep learning-based tumor-only somatic mutation classifier achieves high accuracy agnostic of tissue type and capture kit.
Robert T. McLaughlin, Maansi Asthana, … David L. Masica·bioRxiv·Dec 7, 2021